Seth Lerner, MD
Urology · Houston, TXNPI 1669552063
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $87,419 of the $97,873 with a category attached, or 89.3%. It is spread thinly across 21 manufacturers, the largest accounting for just 18.9%. Reporting peaked in 2020 at $22,944 and has fallen 58.6% since, to $9,509 in 2025. Among urology clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 90 payments — averaging $1087.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Ferring Pharmaceuticals AS$18K
- Urogen Pharma, Inc.$16K
- Merck$16K
- Ferring Pharmaceuticals Inc.$13K
- E.r. Squibb & Sons, L.L.C.$9K
- Gilead$5K
- plus $20K from 15 others
Across 1 payment — averaging $19,575 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- QED Therapeutics, Inc.$20K
What the payments were for
- Consulting fees$87,41989%
- Speaking & faculty fees$3,3003%
- Travel & lodging$4,2834%
- Food & beverage$2,8713%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Ferring Pharmaceuticals AS | 9 | $18,491 |
| Urogen Pharma, Inc. | 2 | $16,230 |
| Merck | 12 | $16,009 |
| Ferring Pharmaceuticals Inc. | 20 | $12,859 |
| E.r. Squibb & Sons, L.L.C. | 8 | $9,378 |
| Gilead | 7 | $4,866 |
| Ferring International Center SA | 1 | $4,822 |
| Genentech, Inc. | 7 | $4,302 |
| Astrazeneca UK Limited | 2 | $3,491 |
| AstraZeneca | 1 | $2,148 |
| Pfizer | 1 | $2,000 |
| Verity Pharmaceuticals Inc. | 1 | $1,600 |
| Genentech USA, Inc. | 6 | $900 |
| Immunitybio, Inc. | 1 | $200 |
| QED Therapeutics, Inc. | 1 | $135 |
| Boston Scientific | 2 | $131 |
| EMD Serono, Inc. | 1 | $87 |
| AbbVie | 4 | $76 |
| Intuitive Surgical | 2 | $60 |
| ABC Home Medical Supply, Inc. | 1 | $51 |
| Janssen Global Services, LLC | 1 | $36 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$97,873 in reported general payments places this provider in the 95th percentile of 878 urology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tamsulosin Hcl | 41 | $434 |
| Oxybutynin Chloride | 20 | $373 |
| Finasteride | 34 | $311 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 31 | $302 |
| Oxybutynin Chloride ErOxybutynin Chloride | 15 | $301 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 31 | $277 |
| Sodium Chloride0.9 % Sodium Chloride | 25 | $254 |
| Ciprofloxacin Hcl | 40 | $214 |
| Sodium ChlorideSodium Chloride Irrig Solution | 19 | $186 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 33 | $114 |
| Tramadol Hcl | 21 | $41 |
Paid to pharmacies, not to this prescriber.
Other urology in Houston
- Arun RaiHouston$920K
- Donald GriffithHouston$732K
- Jonathan Clavell HernandezHouston$500K
- Ashish KamatHouston$481K
- Mohit KheraHouston$428K
- Ricardo GonzalezHouston$314K
- Richard LinkHouston$261K
- Steven CanfieldHouston$256K
- Run WangHouston$195K
- Kathleen KobashiHouston$159K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.